13F
中

GRCE GRACE THERAPEUTICS INC

2026Q1 · CUSIP 00439U104 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
34
Δ holders QoQ
+12
Breadth percentile
Top 25%
Whale holders
16
Δ whales
+6
Inst. holding value
$20M
New positions
18
Closed positions
6
Price momentum (1Q)
—
Put / Call
1/1

Breadth history (34 quarters)

2024Q4: Δ+15 · h=16 2025Q1: Δ+2 · h=18 2025Q2: Δ+3 · h=21 2025Q3: Δ-1 · h=20 2025Q4: Δ+2 · h=22 2026Q1: Δ+12 · h=34 2024Q4: holders=16 2025Q1: holders=18 2025Q2: holders=21 2025Q3: holders=20 2025Q4: holders=22 2026Q1: holders=34 -15 -7.5 +0 +7.5 +15 142536 24Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
1
QoQ: +1
Call holders
1
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.47
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.61 2022-09-30: EPS -0.66 2022-12-31: EPS -0.52 2023-03-31: EPS -3.92 2023-06-30: EPS -0.54 2023-09-30: EPS -0.43 2023-12-31: EPS -0.21 2024-03-31: EPS -0.17 2024-06-30: EPS -0.24 2024-09-30: EPS -0.30 2024-12-31: EPS -0.36 2025-06-30: EPS -0.21 2025-09-30: EPS -0.06 2025-12-31: EPS -0.14 2026-03-31: EPS -0.06 -4.31 -2.16 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)